You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally%20Advanced

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcoma, Soft Tissue Trial in Worldwide (Nintedanib, Ifosfamide)

Terminated
  • Sarcoma, Soft Tissue
  • Brussels, Belgium
  • +12 more
Sep 10, 2021

COPD, Depression Trial in Seattle (CLIMB (COPD Lifestyle, Mood, and Behavior))

Completed
  • COPD
  • Depression
  • CLIMB (COPD Lifestyle, Mood, and Behavior)
  • Seattle, Washington
    University of Washington
Sep 27, 2021

Nasopharyngeal Carcinoma Trial in Guangzhou (GP+DDP, Palbociclib, Intensity-modulated radiotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 2, 2021

Lung Cancer Stage II Trial (Camrelizumab+ pemetrexed + platinum)

Not yet recruiting
  • Lung Cancer Stage II
  • Camrelizumab+ pemetrexed + platinum
  • (no location specified)
Jul 16, 2021

Hepatocellular Carcinoma, Radiotherapy, Lenvatinib Trial in Beijing (concurrent lenvatinib and Radiotherapy, followed lenvatinib

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • concurrent lenvatinib and Radiotherapy, followed lenvatinib maintenance
  • Beijing, Beijing, China
    Bo Chen
Dec 19, 2021

Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)

Completed
  • Bladder Cancer
  • Metastatic Transitional Cell Carcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 16, 2021

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (autologous or syngeneic PBTLs and EBV-CTLs)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • autologous or syngeneic PBTLs and EBV-CTLs
  • Houston, Texas
  • +1 more
Feb 6, 2022

Gastric Cancer, Adjuvant Chemo, XO Trial in Seoul (Docetaxel and capecitabine and oxaliplatin, capecitabine and oxaliplatin)

Recruiting
  • Gastric Cancer, Adjuvant Chemotherapy, XO
  • Docetaxel and capecitabine and oxaliplatin
  • capecitabine and oxaliplatin
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 30, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +7 more
  • Aurora, Colorado
  • +7 more
Nov 29, 2022

Advanced NSCLC Trial (VIC-1911, Osimertinib Mesylate Tablets)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer
  • (no location specified)
Aug 3, 2022

Urothelial Carcinoma Trial in Seoul (tipifarnib)

Active, not recruiting
  • Urothelial Carcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 6, 2022

Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

Active, not recruiting
  • Cholangiocarcinoma
  • +5 more
  • Gilbert, Arizona
  • +57 more
Jan 5, 2022

Advanced Non-Small Cell Lung Carcinoma Trial in Worldwide (SDREGN2810, SDREGN2810/ipi, HDREGN2810)

Completed
  • Advanced Non-Small Cell Lung Carcinoma
  • Phoenix, Arizona
  • +30 more
Nov 16, 2021

Advanced or Metastatic Esophageal Squamous Cell Carcinoma Trial in Worldwide (RO7121661, RO7247669, Nivolumab)

Recruiting
  • Advanced or Metastatic Esophageal Squamous Cell Carcinoma
  • Buenos Aires, Argentina
  • +79 more
Aug 3, 2022

Carcinoma, Squamous Cell of Head and Neck (HNSCC), Melanoma, NSCLC (NSCLC) Trial in Amsterdam (BI 765063, Ezabenlimab, [89Zr]Zr-

Recruiting
  • Carcinoma, Squamous Cell of Head and Neck (HNSCC)
  • +2 more
  • BI 765063
  • +4 more
  • Amsterdam, Netherlands
    Amsterdam UMC Locatie VUMC
Jan 9, 2023

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Carcinoma, Renal Cell, Clear-cell Metastatic Renal Cell Carcinoma Trial in Worldwide (Nivolumab/Ipilimumab)

Active, not recruiting
  • Carcinoma, Renal Cell
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab/Ipilimumab
  • Linz, Austria
  • +34 more
Aug 3, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Anti-TGF-beta Monoclonal Antibody SAR-439459
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Endometrial Cancer Trial in Canada (Niraparib, TSR-042)

Active, not recruiting
  • Endometrial Cancer
  • Calgary, Alberta, Canada
  • +6 more
Nov 18, 2021

Tumors, NSCLC Trial in Worldwide (BI 754111, BI 754091)

Active, not recruiting
  • Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • BI 754111
  • BI 754091
  • Miami, Florida
  • +14 more
Jan 9, 2023

Associated With Chemotherapy-Induced Nerve Damage

Terminated
  • Peripheral Neuropathic Pain
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 4, 2019

    Cholangiocarcinoma Trial in Nanjing (Radiotherapy)

    Recruiting
    • Cholangiocarcinoma
    • Radiotherapy
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Apr 27, 2021

    NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Esophageal Squamous Cell Carcinoma Trial in Zhengzhou (Nimotuzumab + SHR-1210)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Nimotuzumab + SHR-1210
    • Zhengzhou, Henan, China
      The First Affiliated Hospital of Zhengzhou University
    Jul 6, 2021

    Small Cell Lung Cancer Trial in Japan (Rovalpituzumab tesirine)

    Completed
    • Small Cell Lung Cancer
    • Rovalpituzumab tesirine
    • Kashiwa-shi, Chiba, Japan
    • +4 more
    Jul 28, 2021